womens-precision-prevention-supports-world-go-day

Women’s Precision Prevention supports World GO Day

20. 9. 2026
United Kingdom

Women’s Precision Prevention supports World Gynecologic Oncology Day on Social Media.


Organization

The Women’s Precision Prevention (WPP) team was founded by Professor Manchanda in 2015. We are based at the Wolfson Institute of Population Health at Queen Mary University of London (QMUL). Our clinical work is based at Barts Health NHS Trust. Our research is multi-disciplinary and focused on targeted precision prevention of women’s cancers. This includes population-based genetic testing, mainstreaming genetic testing, and precision medicine approaches for risk prediction, population stratification, targeted screening and targeted cancer prevention, along with health economic issues related to these areas. We lead research studies and clinical trials in precision prevention, and collaborate with many national and international researchers, stakeholders and health professionals. We work Guideline Developers and Policy Makers. Our research has informed number of national and international guidelines and policy.